Agios Pharmaceuticals, Inc. (AGIO)
26.81
-0.47
(-1.72%)
USD |
NASDAQ |
Dec 09, 16:00
26.85
+0.04
(+0.15%)
After-Hours: 20:00
Agios Pharmaceuticals Total Assets (Quarterly): 1.386B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Pfizer Inc. | 208.73B |
| Fulcrum Therapeutics, Inc. | 214.86M |
| Moderna, Inc. | 12.14B |
| EyePoint Pharmaceuticals, Inc. | 251.70M |
| Vanda Pharmaceuticals, Inc. | 601.14M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 101.38M |
| Shareholders Equity (Quarterly) | 1.284B |
| Debt to Equity Ratio | 0.0347 |
| Current Ratio | 13.82 |
| Net Debt Paydown Yield | 0.17% |